Infectious Disease Surveillance: A Cornerstone for Prevention and Control

Infectious Disease Surveillance: First Edition

Volumn , Issue , 2008, Pages 1-17

  M'ikanatha, Nkuchia M ^a   Lynfield, Ruth ^b   Julian, Kathleen G ^c   Van Beneden, Chris A ^d   De Valk, Henriette ^e  

^a PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Disease control; Immunodeficiency virus; Infectious disease; Polio virus; Public health

Indexed keywords

EID: 84891542274     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470692097.ch1     Document Type: Chapter

References (45)

1. Hong Kong Health Commitment Pledged in Sweden. Available from: http://www.news-medical.net/?id=5119. Accessed October 16, 2005.
2. Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis 2001;32:675-85.
3. Health Protection Agency. Health protection in the 21st century. Available from: http://www.hpa.org.uk/publications/2005/burden disease/default.htm. Accessed November 1, 2006.
4. Knobler S, Mahmoud A, Lemon S, Mack, A, Sivitz L and Oberholtzer K (eds). Workshop summary. In: Learning from SARS: Preparing for the Next Disease Outbreak. Washington, DC: National Academies Press; 2004:11.
5. World Health Assembly. Revision of the International Health Regulations, WHA58.3. 2005. Available from: http://www.who.int/gb/ebwha/pdf files/WHA58-REC1/english/Resolutions.pdf. Accessed on October 27, 2006.
6. Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication-Eastern Mediterranean Region, January 2000-September 2001. Morb Mortal Wkly Rep 2001;50:1113-6.
7. Ekwanzala M, Pepin J, Khonde N, Molisho S, Bruneel H, De Wals P. In the heart of darkness: sleeping sickness in Zaire. Lancet November 23, 1996;348:1427-30.
8. Merson MH. The HIV-AIDS pandemic at 25-the global response. N Engl J Med 2006;354:2414-7.
9. Berkelman RL, Bryan RT, Osterholm MT, LeDuc JW, Hughes JM. Infectious disease surveillance: a crumbling foundation. Science 1994;264:368-70.
10. Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000;181(suppl 1):S10-22.
11. World Health Organization. The vector-borne human infections of Europe: their distribution and burden on public health. Available from: http://www.euro.who.int/document/E82481.pdf. Accessed November 7, 2006.
12. Sharma VP, Mehrotra KN. Malaria resurgence in India: a critical study. Soc Sci Med 1986;22:835-45.
13. World Health Assembly. Global influenza surveillance. Available from: http://www.who.int/csr/disease/in fluenza/influenzanetwork/en/index.html. Accessed November 3, 2006.
14. Centers for Disease Control and Prevention. Efficacy and Effectiveness of Inactivated Influenza Vaccine. Available from: http://www.cdc.gov/flu/professionals/vaccination/efficacy.htm. Accessed November 9, 2006.
15. Van Beneden CA, Whitney CG, Levine OS, for the Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(RR-9): 1-38.
16. Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-7):1-38.
17. Fridkin SK, Hageman JC, Morrison M, et al., Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. NEngl JMed 2005;352:1436-44.
18. World Health Organization. Monitoring antimalarial drug resistance. Report of aWHO consultation, Geneva, Switzerland, December 3-5, 2001.
19. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxoneresistant salmonella infection acquired by a child from cattle. N Engl J Med 2000;342:1242-9.
20. Danish Integrated Antimicrobial Resistance Monitoring and Research Programme. Monitoring antimicrobial resistance in Denmark. Int J Antimicrob Agents 2000;14:271-4.
21. Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001;45:2054-9.
22. Mokotoff ED, Glynn MK. Surveillance for HIV/AIDS in the United States. In: M'ikanatha NM, Lynfield R, Van Beneden CA, De Valk H (eds), Infectious Disease Surveillance. London: Blackwell; 2007:201-11.
23. United Nations Programs on HIV/AIDS. Uniting the World Against AIDS. Available from: http://www.unaids. org/en/HIV data/default.asp. Accessed November 7, 2006.
24. Bill and Melinda Gates Foundation. Available from: http://www.gatesfoundation.org/default.htm. Accessed December 26, 2006.
25. Centers for Disease Control and Prevention. PulseNet. Available from: http://www.cdc.gov/pulsenet/index. htm. Accessed November 9, 2006.
26. Barrett, TJ, Lior, H, Green, JH, et al. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol 1994;32:3013-17.
27. Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA 1994;272:1349-53.
28. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol 2002;155:866-74.
29. Bannister BA, Begg NT, Gillespie SH. Infectious Diseases. London: Blackwell Science; 1996:455.
30. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997;46(RR-10):1-55.
31. Smith PF, Birkhead GS. Electronic clinical laboratory reporting for public health surveillance. In: M'ikanatha NM, Lynfield R, Van Beneden CA, De ValkH(eds), Infectious Disease Surveillance. London: Blackwell; 2007:Pt 2, 339-48.
32. Commonwealth of Australia. Australian notifiable diseases case definitions. Available from: http://www. health.gov.au/internet/wcms/publishing.nsf/Content/cda-surveil-nndss-casedefs-epilink.htm#epi. Accessed November 27, 2006.
33. Schwarcz SK, Hsu LC, Parisi MK, Katz MH. The impact of the 1993 AIDS case definition on the completeness and timeliness of AIDS surveillance. AIDS 1999;13:1109-14.
34. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al European Antimicrobial Resistance Surveillance System Participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627-34.
35. World Health Organization. Global Salm-Surv. Available from: http://www.who.int/salmsurv/en/. Accessed November 5, 2006.
36. Centers for Disease Control and Prevention. FoodNet Surveillance. Available from: http://www.cdc.gov/foodnet/surveillance.htm. Accessed November 5, 2006.
37. Gregson S, Terceira N, Kakowa M, et al. Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS 2002;16:643-52.
38. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 2006;44:1851-2.
39. Centers for Disease Control and Prevention (CDC). Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1996;45:729-33.
40. Centers for Disease Control and Prevention. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Morb Mortal Wkly Rep 2006;55(SS-6):1-16.
41. CDC. Youth Risk Behavior Surveillance-United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51(SS04):1-64.
42. Fine A, Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis 2001;32:277-82.
43. Constella Group. Constella Health Sciences Rewins CDC and FDA's $21 Million Vaccine Adverse Event Reporting System Contract. Available from: http://www.constellagroup.com/news/news releases/2004/010404. shtml. Accessed November 27, 2006.
44. Hardiman BJM, González-Martin F, Rodier G. Infectious disease surveillance and the International Health Regulations. In: M'ikanatha NM, Lynfield R, Van Beneden CA, De ValkH(eds), Infectious Disease Surveillance. London: Blackwell; 2007:18-31.
45. Foege WH, Hogan RC, Newton LH. Surveillance projects for selected diseases. Int J Epidemiol 1976;5:29-37.